The Semanext Reusable Pen Injector is a reusable injection pen developed by Cipla Ltd. It is designed to administer Semaglutide, a synthetic form of parathyroid hormone (PTH), used to treat osteoporosis. Osteoporosis is a condition characterised by weakened bones, which increases the risk of fractures. This device facilitates the subcutaneous injection of Semaglutide, promoting bone formation and strength.